Research News and Research

RSS

Pancreatic cancer could be better managed at specialized surgical centres

Pancreatic cancer is one of Australia's most lethal cancers and according to a surgeon it could be better treated by conducting complex surgical procedures in specialised centres. Pancreatic cancer is the fourth biggest cancer killer in Australia.

8 May 2012

Halozyme first quarter net loss increases to $15.1 million

Halozyme Therapeutics, Inc. today reported financial results for the quarter ended March 31, 2012.

8 May 2012

High rates of birth defects associated with an artificial reproductive technology: Study

A new study has shown that one of the most popular forms of IVF could double the risk of birth defects.

8 May 2012

Abbott to resolve all outstanding issues related to Depakote

Abbott has reached a settlement with U.S. federal and 49 state authorities, plus the District of Columbia, to resolve all outstanding issues regarding a previously disclosed investigation of past sales and marketing practices relating to its neurologic medication Depakote.

8 May 2012

Campaign announces search for Arizona teens to participate in Addicteen

Arizona's anti-smoking youth campaign, Venomocity Brought to You by Addiction announces a search for Arizona teens to participate in Addicteen, a documentary about addiction. The film will examine activities which teenagers have defined as being addictive including, texting, social media and the use of tobacco. Filmmakers seek to draw out the similarities, differences and impacts of these behaviors on the lives of today's youth.

8 May 2012

Maxygen first quarter net loss increases to $2.6 million

Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter ended March 31, 2012.

8 May 2012

FRAX version 3.6 now available for 45 countries, in 19 languages

The WHO Fracture Risk Assessment Tool - FRAX- has now been released as version 3.6 with new country models for Chile, Greece, Indonesia, Ireland and Lithuania. Downloadable charts for the newly added countries are also available.

8 May 2012

Salix first quarter total product revenue increases 62% to $171.1M

Salix Pharmaceuticals, Ltd. today announced financial and operating results for the first quarter ended March 31, 2012 and other business updates.

8 May 2012

Comfort Solutions commits to raise $1M for St. Jude Children's Research Hospital

Comfort Solutions has committed to raising $1 million by March 31, 2013, for St. Jude Children's Research Hospital, becoming the first major U.S. mattress company to support the world-renowned hospital that impacts children globally.

8 May 2012

Landauer second quarter revenue increases 21% to $39.1 million

Landauer, Inc., a recognized leader in personal and environmental radiation monitoring, outsourced medical physics services and high quality medical consumable accessories, today reported financial results for its fiscal 2012 second quarter ended March 31, 2012.

8 May 2012

Oncothyreon first quarter net income increases to $9.7 million

Oncothyreon Inc. today reported financial results for the first quarter ending March 31, 2012.

8 May 2012

DBS may offer hope for patients with mild Alzheimer's

A study on a handful of people with suspected mild Alzheimer's disease (AD) suggests that a device that sends continuous electrical impulses to specific "memory" regions of the brain appears to increase neuronal activity. Results of the study using deep brain stimulation, a therapy already used in some patients with Parkinson's disease and depression, may offer hope for at least some with AD, an intractable disease with no cure.

8 May 2012

T2M cells play a crucial role in treatment-resistant asthma

For most people with asthma, a couple of puffs from an inhaler filled with steroids makes breathing easy. But if their lungs become resistant to the calming effect of that medicine, they live in fear of severe asthma attacks that could send them to the hospital - or worse. Now, new research from the University of Michigan Health System may help explain what's going on in the lungs of these steroid-resistant individuals. The findings could aid the development of new treatment options, and of better ways to identify people at risk of becoming steroid-resistant.

8 May 2012

Researchers discover CD19 pathway that leads to lymphoma

Researchers studying the molecular signals that drive a specific type of lymphoma have discovered a key biological pathway leading to this type of cancer. Cancerous cells have been described as being "addicted" to certain oncogenes (cancer-causing genes), and the new research may lay the groundwork for breaking that addiction and effectively treating aggressive types of B cell lymphoma.

8 May 2012

New data from Acucela’s ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

8 May 2012

Clinverse closes $3.8 million Series B round of funding

Clinverse, Inc., the global cloud-based ecommerce platform provider for clinical trials, announced today that it has closed a $3.8 million Series B round of funding led by Hatteras Venture Partners of Durham, NC. Vital Financial of Bethesda, MD, also participated in this funding round.

8 May 2012

Zinc oxide could increase risk of skin cancer

As vacationers prepare to spend time outdoors this summer, many of them will pack plenty of sunscreen in hopes it will protect their bodies from overexposure, and possibly from skin cancer. But researchers at Missouri University of Science and Technology are discovering that sunscreen may not be so safe after all.

8 May 2012

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S today announced results from a Phase 3 clinical trial evaluating the efficacy, safety and tolerability of once-monthly aripiprazole intramuscular (IM) depot formulation for the maintenance treatment of adults with schizophrenia.

8 May 2012

Affymax first quarter total revenue increases to $63.2 million

Affymax, Inc. today reported financial results for the first quarter ended March 31, 2012. The net income for the first quarter of 2012 was $31.5 million (or $0.87 per share) compared to a net loss of $9.6 million (or $(0.36) per share) for the first quarter of 2011.

8 May 2012

State roundup: Calif. fight over group homes for seniors; New agency proposed to police disabled care in NY; Conn. retiree health plan expansion could endanger protections

Neighbors were already concerned about the growing number of group homes for the elderly and recovering addicts in the area, many of them for profit. A Times analysis found 24 licensed facilities offering residential care for the elderly within a mile of the proposed project and three more waiting for state approval. It is one of several such clusters that have emerged in Los Angeles County -- including parts of the San Fernando Valley and South Bay -- where families can afford fees that run into thousands of dollars per month. Large swaths of the county's less affluent areas have no such facilities.

8 May 2012